Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 27, 2021
October 1, 2024
2389b45f-e333-46cf-b87b-a1e55f05c775
Related Documents
Investigator Responsibilities – Safety Reporting for Investigational Drugs and Devices: Guidance for Industry
Guidance DocumentDecember 15, 2025Center for Drug Evaluation and Research
A Risk-Based Approach to Monitoring of Clinical Investigations Questions and Answers: Guidance for Industry
Guidance DocumentApril 12, 2023Center for Drug Evaluation and Research
Use of Whole Slide Imaging in Nonclinical Toxicology Studies: Questions and Answers: Guidance for Industry
Guidance DocumentMay 24, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.